A study investigated the effects of i.p. CBD (5 or 20 mg/kg body weight) administration in adult male hyperlocomotive and hyperexplorative Fmr1 KO mice and wild-type mice, an experimental model used to investigate FXS. Here, FMR1 is linked to fragile X syndrome.